Variation in Sedation and Neuromuscular Blockade Regimens on Outcome After Cardiac Arrest*

Objectives: Sedation and neuromuscular blockade protocols in patients undergoing targeted temperature management after cardiac arrest address patient discomfort and manage shivering. These protocols vary widely between centers and may affect outcomes. Design: Consecutive patients admitted to 20 centers after resuscitation from cardiac arrest were prospectively entered into the International Cardiac Arrest Registry between 2006 and 2016. Additional data about each center’s sedation and shivering management practice were obtained via survey. Sedation and shivering practices were categorized as escalating doses of sedation and minimal or no neuromuscular blockade (sedation and shivering practice 1), sedation with continuous or scheduled neuromuscular blockade (sedation and shivering practice 2), or sedation with as-needed neuromuscular blockade (sedation and shivering practice 3). Good outcome was defined as Cerebral Performance Category score of 1 or 2. A logistic regression hierarchical model was created with two levels (patient-level data with standard confounders at level 1 and hospitals at level 2) and sedation and shivering practices as a fixed effect at the hospital level. The primary outcome was dichotomized Cerebral Performance Category at 6 months. Setting: Cardiac arrest receiving centers in Europe and the United states from 2006 to 2016 Patients: Four-thousand two-hundred sixty-seven cardiac arrest patients 18 years old or older enrolled in the International Cardiac Arrest Registry. Interventions: None. Measurements and Main Results: The mean age was 62 ± 15 years, 36% were female, 77% out-of-hospital arrests, and mean ischemic time was 24 (± 18) minutes. Adjusted odds ratio (for age, return of spontaneous circulation, location of arrest, witnessed, initial rhythm, bystander cardiopulmonary resuscitation, defibrillation, medical history, country, and size of hospital) was 1.13 (0.74–1.73; p = 0.56) and 1.45 (1.00–2.13; p = 0.046) for sedation and shivering practice 2 and sedation and shivering practice 3, respectively, referenced to sedation and shivering practice 1. Conclusion: Cardiac arrest patients treated at centers using as-needed neuromuscular blockade had increased odds of good outcomes compared with centers using escalating sedation doses and avoidance of neuromuscular blockade, after adjusting for potential confounders. These findings should be further investigated in prospective studies.

[1]  Khalid Aziz,et al.  2019 American Heart Association Focused Update on Neonatal Resuscitation: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care , 2019, Pediatrics.

[2]  G. Nichol,et al.  Continuous versus intermittent neuromuscular blockade in patients during targeted temperature management after resuscitation from cardiac arrest-A randomized, double blinded, double dummy, clinical trial. , 2017, Resuscitation.

[3]  C. Youn,et al.  Neuromuscular blockade requirement is associated with good neurologic outcome in cardiac arrest survivors treated with targeted temperature management , 2017, Journal of critical care.

[4]  G. Wells,et al.  Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Position Statement on the Optimal Care of the Postarrest Patient. , 2017, The Canadian journal of cardiology.

[5]  M. Meade,et al.  Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient. , 2016, Critical care medicine.

[6]  D. Seder,et al.  Analgesia, sedation, and neuromuscular blockade during targeted temperature management after cardiac arrest. , 2015, Best practice & research. Clinical anaesthesiology.

[7]  Mary Ann Peberdy,et al.  Part 8: Post–Cardiac Arrest Care 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care , 2015, Circulation.

[8]  K. Cha,et al.  Adverse events associated with poor neurological outcome during targeted temperature management and advanced critical care after out-of-hospital cardiac arrest , 2015, Critical Care.

[9]  Laalitha Surapaneni,et al.  Daily Interruption of Sedative Infusions in Critically Ill Patients Undergoing Mechanical Ventilation , 2015 .

[10]  D. Seder,et al.  Moderate-Dose Sedation and Analgesia During Targeted Temperature Management After Cardiac Arrest , 2015, Neurocritical Care.

[11]  J. Reignier,et al.  Neuromuscular blockade during therapeutic hypothermia after cardiac arrest: observational study of neurological and infectious outcomes. , 2014, Resuscitation.

[12]  S. Trzeciak,et al.  Arterial Blood Pressure and Neurologic Outcome After Resuscitation From Cardiac Arrest* , 2014, Critical care medicine.

[13]  T. Noonan.  Continuous neuromuscular blockade is associated with decreased mortality in post-cardiac arrest patients. , 2014, Resuscitation.

[14]  S. Hénard,et al.  Primary Cerebral Alveolar Echinococcosis: Mycology to the Rescue , 2013, Journal of Clinical Microbiology.

[15]  C. Callaway,et al.  Continuous neuromuscular blockade is associated with decreased mortality in post-cardiac arrest patients. , 2013, Resuscitation.

[16]  B. Abella,et al.  Higher mean arterial pressure with or without vasoactive agents is associated with increased survival and better neurological outcomes in comatose survivors of cardiac arrest , 2013, Intensive Care Medicine.

[17]  J. Lundbye,et al.  The occurrence of shivering in cardiac arrest survivors undergoing therapeutic hypothermia is associated with a good neurologic outcome. , 2013, Resuscitation.

[18]  P. Klepstad,et al.  Effects of Hypothermia on the Disposition of Morphine, Midazolam, Fentanyl, and Propofol in Intensive Care Unit Patients , 2013, Drug Metabolism and Disposition.

[19]  K.,et al.  Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the Intensive Care Unit: executive summary. , 2013, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[20]  S. Lydersen,et al.  Propofol and remifentanil versus midazolam and fentanyl for sedation during therapeutic hypothermia after cardiac arrest: a randomised trial , 2012, Intensive Care Medicine.

[21]  Thomas M. Smith,et al.  Timing of neuroprognostication in postcardiac arrest therapeutic hypothermia* , 2012, Critical care medicine.

[22]  Stef van Buuren,et al.  MICE: Multivariate Imputation by Chained Equations in R , 2011 .

[23]  M. Mlynash,et al.  Sedation Confounds Outcome Prediction in Cardiac Arrest Survivors Treated with Hypothermia , 2011, Neurocritical care.

[24]  S. Mayer,et al.  Prevention of Shivering During Therapeutic Temperature Modulation: The Columbia Anti-Shivering Protocol , 2011, Neurocritical care.

[25]  S. Black.  Anesthesia and Analgesia Protocol During Therapeutic Hypothermia After Cardiac Arrest: A Systematic Review , 2011 .

[26]  S. Frangos,et al.  Effect of Shivering on Brain Tissue Oxygenation During Induced Normothermia in Patients With Severe Brain Injury , 2010, Neurocritical care.

[27]  J. Parrillo,et al.  Significance of arterial hypotension after resuscitation from cardiac arrest* , 2009, Critical care medicine.

[28]  N. Weiss,et al.  Randomized trial of light versus deep sedation on mental health after critical illness* , 2009, Critical care medicine.

[29]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[30]  Ingeborg H. F. Herold,et al.  Therapeutic hypothermia and controlled normothermia in the intensive care unit: Practical considerations, side effects, and cooling methods* , 2009, Critical care medicine.

[31]  J. Parrillo,et al.  Early arterial hypotension is common in the post-cardiac arrest syndrome and associated with increased in-hospital mortality. , 2008, Resuscitation.

[32]  S. Mayer,et al.  Metabolic Impact of Shivering During Therapeutic Temperature Modulation: The Bedside Shivering Assessment Scale , 2008, Stroke.

[33]  Sylvain Ladoire,et al.  Effect of a nurse-implemented sedation protocol on the incidence of ventilator-associated pneumonia* , 2007, Critical care medicine.

[34]  P. Kochanek,et al.  Effects of hypothermia on drug disposition, metabolism, and response: A focus of hypothermia-mediated alterations on the cytochrome P450 enzyme system , 2007, Critical care medicine.

[35]  G. Shorten,et al.  The effects of propofol on neutrophil function, lipid peroxidation and inflammatory response during elective coronary artery bypass grafting in patients with impaired ventricular function. , 2006, British journal of anaesthesia.

[36]  A. Lupp,et al.  The Effect of Mild Hypothermia on Plasma Fentanyl Concentration and Biotransformation in Juvenile Pigs , 2005, Anesthesia and analgesia.

[37]  Sabita Roy,et al.  Morphine Impairs Host Innate Immune Response and Increases Susceptibility to Streptococcus pneumoniae Lung Infection1 , 2005, The Journal of Immunology.

[38]  B. de Jonghe,et al.  Sedation algorithm in critically ill patients without acute brain injury , 2005, Critical care medicine.

[39]  G Sherman,et al.  Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. , 1999, Critical care medicine.

[40]  R. Narayan,et al.  Propofol in the treatment of moderate and severe head injury: a randomized, prospective double-blinded pilot trial. , 1999, Journal of neurosurgery.

[41]  G Sherman,et al.  The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. , 1998, Chest.

[42]  P. Safar,et al.  Hypertension With Hemodilution Prevents Multifocal Cerebral Hypoperfusion After Cardiac Arrest in Dogs , 1992, Stroke.

[43]  P. Safar,et al.  Hypertension with or without hemodilution after cardiac arrest in dogs. , 1990, Stroke.